CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Open-market buy Member of 10% owner group bought 2,000 shares at $2.58 ($5,160)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Member of 10% owner group bought 9,200 shares at $2.34 ($21,528)
- 4 Grant or award Director acquired 8,666 shares (grant or award)
- 4 Grant or award Director acquired 8,666 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 8,500 shares at $3.04 ($25,840)
- 4 Open-market buy Chief Financial Officer bought 41,500 shares at $2.92 ($121,180)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 500 shares at an average $3.60 ($1,798)
- 4 Open-market buy Member of 10% owner group bought 8,600 shares at an average $4.06 ($34,895)
Page 9 of 17 · 329 filings